Results 41 to 50 of about 45,910 (249)
Journal of the European Academy of Dermatology and Venereology, 2021 Autoimmune bullous diseases (AIBD) are rare disorders characterized by autoantibody formation against components of adhesion molecules; in pemphigoid diseases (PD), these are proteins of hemidesmosomes and basement membrane, important for cell‐matrix ...
N. Beek +15 more
semanticscholar +1 more source
IgE autoantibodies and their association with the disease activity and phenotype in Bullous Pemphigoid: a systematic review [PDF]
, 2017 Bullous Pemphigoid (BP) is the most common autoimmune skin disease of blistering character. The underlying pathophysiological mechanism involves an immune attack, usually by IgG class autoantibodies, on the autoantigen BP 180/BPAg2, which is a type XVII ...
Fairclough, Lucy C. +3 more
core +2 more sources
S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2020 (1) Department of Dermatology, University of Lübeck, Lübeck, Germany (2) Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany (3) Department of Dermatology, University Hospital Erlangen, Erlangen, Germany (4) Department of ...
Enno Schmidt +17 more
semanticscholar +1 more source
Dermatology Online Journal, 2021 Immune checkpoint inhibitors, a relatively new class of drugs, are used to treat a variety of malignancies. These drugs have a known association with cutaneous side effects, such as bullous pemphigoid. Bullous pemphigoid is a pruritic blistering disorder
E. Klepper, H. N. Robinson
semanticscholar +1 more source
Pemphigoid diseases in infancy and childhood. A review of the literature
Przegląd Dermatologiczny, 2023 Bullous pemphigoid is an autoimmune blistering disease that very rarely affects children. Clinical differences in locations of skin lesions led to the distinction of infantile versus childhood pemphigoid. Mucous membranes can be affected.
Magdalena Jałowska +2 more
doaj +1 more source
Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial. [PDF]
, 2015 BackgroundToxic epidermal necrolysis (TEN) is a rare systemic allergic drug eruption with high patient mortality. Currently, no established treatments have been shown to be effective for TEN beyond supportive care.
Kim, Kyoungmi +6 more
core +4 more sources
Indian Journal of Dermatology, Venereology, and Leprology, 2011 Bullous pemphigoid (BP) is a relatively common autoimmune vesicobullous disease encountered in India. It is a subepidermal bullous disorder most commonly seen in the elderly and manifests as tense blisters on urticarial base, predominantly over flexures, and is associated with pruritus.
Sujay, Khandpur, Parul, Verma
openaire +2 more sources
Bullous Pemphigoid: Trigger and Predisposing Factors
Biomolecules, 2020 Bullous pemphigoid (BP) is the most frequent autoimmune subepidermal blistering disease provoked by autoantibodies directed against two hemidesmosomal proteins: BP180 and BP230.
F. Moro +4 more
semanticscholar +1 more source
British Journal of Dermatology, 2021 Dear Editor, Growing evidence suggests that SARS-CoV-2 vaccination is associated with a variety of cutaneous reactions, also including autoimmune-mediated conditions such as autoimmune blistering diseases such as bullous pemphigoid (BP).1,2 We report new-
T. Gambichler +15 more
semanticscholar +1 more source
Субэпидермальные буллезные дерматозы [PDF]
, 2019 ПЕМФИГОИД БУЛЛЕЗНЫЙПЕМФИГОИД СЛИЗИСТЫХ ОБОЛОЧЕКПРИОБРЕТЕННЫЙ БУЛЛЕЗНЫЙ ЭПИДЕРМОЛИЗДИАГНОСТИКА ДИФФЕРЕНЦИАЛЬНАЯВо второй части статьи, посвященной дерматозам с субэпидермальным расположением пузырей при гистологическом исследовании, описываются буллезный ...
Катина, М. А. +1 more
core +2 more sources